Dihydroergotoxine

DBCAT001251Pharmacologic class

A mixture of three different hydrogenated derivatives of ERGOTAMINE: DIHYDROERGOCORNINE; DIHYDROERGOCRISTINE; and DIHYDROERGOCRYPTINE. Dihydroergotoxine has been proposed to be a neuroprotective agent and a nootropic agent. A DrugBank category of 2 drugs. 1 of them is approved.

Also known as: Alkaloids, Hydrogenated Ergot · Co-Dergocrine · Dihydroergotoxin · Ergot Alkaloids, Hydrogenated · Hydrogenated Ergot Alkaloids
Drugs: Acetergamine
Ergoloid mesylate

What you can answer from here — as of August 24, 2016

2DrugsEach linked to its full drug card

Listed above

4Drug targetsEvery drug–target pair in the class, with bond type

27Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do Dihydroergotoxine share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account